Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows From Operating Activities:
Net loss	$ (8,057,774)	$ (6,837,989)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	172,680	81,691
Amortization of debt discount	3,271,419	3,502,517
Change in fair value of foreign currency contract	1,737,263	270,400
Changes in assets and liabilities:
Prepaid expenses and other receivables	(1,183,997)	(94,945)
Inventory	(422,197)	(264,604)
Accounts payable	164,794	(102,302)
Due to (from) related parties	223,678	(652,349)
Other liabilities and accrued expenses	(160,662)	151,717
Deferred revenue	(294,288)	469,785
Net cash used in operating activities	(4,549,084)	(3,476,079)
Cash Flows From Investing Activities:
Capitalized patent costs	(144,343)	(47,426)
Capitalized software development costs	(27,879)	(418,794)
Purchase of property and equipment	(208,945)	(220,035)
Net cash used in investing activities	(381,167)	(686,255)
Cash Flows From Financing Activities:
Proceeds from issuance of notes payable	4,700,000	0
Proceeds from warrant exercise	0	2,963,658
Repayments of note payable	(6,274,282)	(3,800,000)
Net cash used in financing activities	(1,574,282)	(836,342)
Effect of exchange rate changes on cash	(1,135,050)	(98,499)
Net decrease in cash	(7,639,583)	(5,097,175)
Cash at beginning of period	17,749,233	31,865,371
Cash at end of period	10,109,650	26,768,196
Supplemental disclosure of non-cash financing activities:
Release of prepayment from equity compensation	0	50,000
Monitoring fees added to notes payable	$ 1,108,896	$ 0